沃戈宁通过激活AMPK-TET2-5hmC轴来抑制卵巢癌
Shu-Yi Yang1,2,3, Jing-Siang Jhang1,4,5, Wen-Long Huang1,2
1Department of Biomedical Sciences, National Chung Cheng University, Min-Hsiung, Chia-Yi, Taiwan.
Molecular carcinogenesis
|December 2, 2024
概括
沃贡尼是一种天然的黄类化合物,抑制卵巢癌的生长和迁移. 它还增强了西斯丁的功效.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 卵巢癌是主要的妇科恶性瘤.
- 需要新的治疗药物.
- 沃戈宁是一种天然的黄类化合物,具有潜在的抗癌特性.
研究的目的:
- 为了研究沃贡宁对卵巢癌细胞的抗癌作用.
- 为了阐明伏戈宁作用背后的分子机制.
- 在体外和体内评估沃贡尼的治疗潜力.
主要方法:
- 使用了A2780和Kuramochi人类卵巢癌细胞系.
- 使用CCK8和伤口愈合试验评估细胞毒性和迁移.
- 在裸体小鼠模型中评估体内疗效,分析AMPK和5hmC水平,并进行RNA-Seq.
主要成果:
- 沃戈宁抑制了卵巢癌细胞的活力和迁移在体外和体内.
- 沃古尼因增加了西斯的细胞毒性,并抑制了与EMT相关的基因和EMT相关的基因的增殖.
- 沃古尼因上调了AMPK信号通路,通过稳定TET2来促进5hmC水平,这表明了DNA脱甲基化.
结论:
- 沃贡尼显示出对抗卵巢癌的显著治疗潜力.
- 沃贡尼可能为具有更高风险的代谢障碍的人提供预防性益处.
- 沃贡因的机制涉及AMPK激活和通过TET2稳定通过DNA脱甲基化.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


